Roche (RHHBY.US) Launches Brand Campaign Ahead of New Drug Release! Wilserdly Targets the Multi-Billion Dollar Breast Cancer Treatment Market

According to Golden Ten Data, Swiss pharmaceutical giant Roche (RHHBY.US) plans to name its new oral breast cancer drug Wilserdly and has registered this name in multiple jurisdictions. According to information from the United States Patent and Trademark Office (USPTO), Roche’s U.S. subsidiary Genentech submitted a trademark application on October 27, intending to register the name in capital letters, along with a floral pattern logo. Roche has also filed applications for the same brand name with regulatory authorities worldwide, including the European Union Intellectual Property Office.